Clinical Trial Update: Chemotherapy of Elderly Patients With Non-Small-Cell Lung Cancer (NSCLC) [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating chemotherapy in elderly patients with non-small cell lung cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Snippet

Sponsor: Intergroupe Francophone de Cancerologie Thoracique | Conditions: NSCLC | Phase 3 | Status: COMPLETED